Viral load monitoring as a tool to reinforce adherence: A systematic review

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 1, 2013, Pages 74-78

  Bonner, Kimberly ^a   Mezochow, Alyssa ^a   Roberts, Teri ^a   Ford, Nathan ^a,b   Cohn, Jennifer ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Adherence; HIV; Viral load; Viremia

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL RESISTANCE; BURKINA FASO; DATA BASE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALI; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SOUTH AFRICA; SWAZILAND; SYSTEMATIC REVIEW; THAILAND; UNITED STATES; VIREMIA; VIRUS LOAD; VIRUS MUTATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHOMETRICS; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 84883453139     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829f05ac     Document Type: Review

References (21)

1. Bartlett JA, Shao JF. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis. 2009;9:637-649
2. Keiser O, Chi BH, Gsponer T, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS. 2011;25:1761-1769
3. Ajose O, Mookerjee S, Mills EJ, et al. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: A systematic review and meta-analysis. AIDS. 2012;26:929-938
4. El-Khatib Z, Delong AK, Katzenstein D, et al. Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa. J AIDS Clin Res. 2011;2
5. WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO Press; 2010. pp. 47-52, 61
6. Wilson D, Keiluhu AK, Kogrum S, et al. HIV-1 viral load monitoring: An opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Trans R Soc Trop Med Hyg. 2009;103:601-606
7. Roberts T, Bygrave H, Fajardo E, et al. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc. 2012;15:17324
8. Khan S, Petros I, Andries A, et al. Second-Line Failure and First Experiences With Third-Line Antiretroviral Therapy in Mumbai, India. London, UK: MSF Scientific Day Abstract; 2013
9. Calmy A, Ford N, Hirschel B, et al. HIV viral load monitoring in resource-limited regions: Optional or necessary? Clin Infect Dis. 2007; 44:128-134
10. Orrell C, Harling G, Lawn SD, et al. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther. 2007;12:83-88
11. DeFino M, Clark J, Mogyoros D, et al. Predictors of virologic success in patients completing a structured antiretroviral adherence program. J Assoc Nurses AIDS Care. 2004;15:60-67
12. Pirkle CM, Boileau C, Nguyen VK, et al. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali. HIV Med. 2009;10:152-156
13. Parker LA, Kiran J, Azih C. Use of Viral Load (VL) Monitoring to Enable Better Targeting of Adherence Support for Antiretroviral Therapy (ART) Compliance in Swaziland. London, UK: MSF Scientific Day Abstract; 2013
14. Berki-Benhaddad Z, Ecobichon JL, Mentre F, et al. [Adherence intervention for HIV-infected patients receiving antiretroviral treatment. Implementation and initial assessment]. Presse Med. 2006;35(9 Pt 1):1241-1248
15. Kahn JG, Marseille E, Moore D, et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: Cost effectiveness study. BMJ. 2011;343:d6884
16. Hamers RL, Sawyer AW, Tuohy M, et al. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: A model-based analysis. AIDS. 2012;26:1663-1672
17. Kimmel AD, Weinstein MC, Anglaret X, et al. Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: Clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;54:258-268
18. Renaud-Thery F, Avila-Figueroa C, Stover J, et al. Utilization patterns and projected demand of antiretroviral drugs in low-and middle-income countries. AIDS Res Treat. 2011;2011:749041
19. Hoare A, Kerr SJ, Ruxrungtham K, et al. Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia. PloS One. 2010;5:e10981
20. MSF MSF. Speed Up Scale-Up: Strategies, Tools and Policies to Get the Best Treatment to More People, Sooner. Geneva, Switzerland: MSF Access Campaign; 2012
21. MSF MSFAC. Undetectable: How Viral Load Monitoring Can Improve HIV Treatment in Developing Countries. Geneva, Switzerland: MSF Access Campaign; 2012